LOTTINI, TIZIANO
 Distribuzione geografica
Continente #
EU - Europa 919
NA - Nord America 633
AS - Asia 146
SA - Sud America 2
AF - Africa 1
Totale 1.701
Nazione #
US - Stati Uniti d'America 631
PL - Polonia 575
IT - Italia 147
IE - Irlanda 79
HK - Hong Kong 55
SE - Svezia 51
CN - Cina 33
JO - Giordania 21
VN - Vietnam 20
RU - Federazione Russa 16
IN - India 11
GB - Regno Unito 10
DE - Germania 9
SG - Singapore 6
BE - Belgio 5
FR - Francia 5
ES - Italia 4
FI - Finlandia 4
CH - Svizzera 3
NL - Olanda 3
AT - Austria 2
BR - Brasile 2
GR - Grecia 2
MT - Malta 2
UA - Ucraina 2
CA - Canada 1
MU - Mauritius 1
MX - Messico 1
Totale 1.701
Città #
Warsaw 574
Fairfield 94
Chandler 79
Dublin 77
Ashburn 60
Florence 50
Hong Kong 44
Woodbridge 41
Cambridge 38
Seattle 33
Ann Arbor 26
Houston 26
Altamura 23
Lawrence 23
Dong Ket 20
Princeton 19
Wilmington 18
Moscow 16
Beijing 14
Shanghai 14
Boston 10
Buffalo 9
New York 8
Medford 7
Pune 7
San Diego 7
Norwalk 6
Brussels 5
Lucca 5
Barcelona 4
Boardman 4
Cagliari 4
Redwood City 4
Rome 4
Andover 3
Falls Church 3
Hillsboro 3
Milan 3
Münster 3
Singapore 3
Bern 2
Bremen 2
Casoria 2
Fondi 2
Hengshui 2
Laurel 2
Letterkenny 2
Lucknow 2
Melita 2
Silea 2
Vienna 2
Washington 2
West Jordan 2
Atlanta 1
Bari 1
Bethesda 1
Cantagallo 1
Catania 1
Cortona 1
Fiesole 1
Hangzhou 1
Kilburn 1
Lastra a Signa 1
London 1
Mexico City 1
Monsummano Terme 1
New Delhi 1
North Bergen 1
Nuremberg 1
Odesa 1
Pavia 1
Phoenix 1
Pisa 1
Pozza di Fassa 1
Redmond 1
Sao Jose do Rio Preto 1
Stevenage 1
São Paulo 1
Terracina 1
Toronto 1
Wuhan 1
Totale 1.445
Nome #
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 232
Advances in hERG1 and LHR based targeting in neoplastic and preneoplastic conditions 228
HERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers 219
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells. 119
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer 118
A Mouse Model for Barrett’s Esophagus: Surgery and Histology 112
The hERG1 potassium channel behaves as prognostic factor in gastric dysplasia endoscopic samples 110
Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging 106
KV11.1 Potassium Channel and the Na+/H+ Antiporter NHE1 Modulate Adhesion-Dependent Intracellular pH in Colorectal Cancer Cells 83
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 77
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 62
Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K 59
Harnessing the hERG1/β1 integrin complex via a novel bispecific single-chain antibody: an effective strategy against solid cancers 53
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis 39
Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses 38
Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection 28
Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma 18
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma 16
Transcriptomic data of bevacizumab-adapted colorectal adenocarcinoma cells HCT-116 15
Expression of the ether-a-gò-gò-related gene 1 channel during B and T lymphocyte development: role in BCR and TCR signaling 8
Corrigendum to "Transcriptomic data of Bevacizumab-adapted colorectal adenocarcinoma cells HCT-116" [Data In Brief, Volume 48, (Available online 17 March 2023) 1-9/Article 109069] 8
Totale 1.748
Categoria #
all - tutte 5.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201954 0 0 0 0 0 0 0 0 0 11 23 20
2019/2020327 12 26 9 11 18 26 35 52 38 37 50 13
2020/2021369 25 49 3 62 20 32 30 26 28 57 11 26
2021/2022183 19 8 18 4 14 12 7 11 22 14 20 34
2022/2023371 30 71 23 14 31 60 40 26 49 4 6 17
2023/2024212 14 16 17 6 14 45 11 62 8 19 0 0
Totale 1.748